Scientists have developed polypeptide-based materials that act as effective vectors for delivering gene therapies. The first-of-its-kind platform enables the vectors to be adapted to suit the specific gene therapy cargo.
Divita Mathur, Research Assistant Professor, is studying cytosolic access and instability of DNA nanoparticles.
An international team of scientists from institutions in Mexico, Spain, and Russia has released promising findings from its study investigating the impact of silver nanoparticles on the transmission of COVID-19.
A research group from KTH has designed nano-sized particles, in an innovative way, to enhance the detection of tumors present inside the body and in biopsy tissue. The progress could allow early-stage tumors to be identified with lower doses of radiation.
Hydrogels are commonly used inside the body to help in tissue regeneration and drug delivery. However, once inside, they can be challenging to control for optimal use.
Graphene-based materials can be obtained using various reducing agents, many of which are dangerous and toxic chemicals, and the obtained graphene-based materials are prone to aggregation, limiting their practical applications.
Parkinson’s disease (PD) is a general neurodegenerative disorder that occurs due to the death of dopaminergic neurons in a part of the brain (called substantia nigra pars compacta), which results in a lack of dopamine (DA), one of the principal neurotransmitters active in the central nervous system.
Dolomite Microfluidics, a leading developer of particle systems for drug delivery, and Phosphorex, Inc., a leading contract development and manufacturing organization specializing in particle-based formulation of drug products, are pleased to announce their partnership to establish unique capabilities in drug and vaccine development.
A collaborative study by Kazan Federal University and Chinese Academy Sciences has been reported in Chemical Engineering Journal.
Scientists from the University of Pittsburgh School of Medicine have demonstrated that inhalable nanobodies can prevent and cure severe COVID-19 in hamsters by targeting the spike protein of the SARS-CoV-2 coronavirus.